Report Detail

Medical Devices & Consumables (Post-pandemic Era)-Global CRISPR/Cas9 Market Segment Research Report 2022

  • RnM4476767
  • |
  • 04 August, 2022
  • |
  • Global
  • |
  • 119 Pages
  • |
  • XYZResearch
  • |
  • Medical Devices & Consumables

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global CRISPR/Cas9 Market Segment Research Report 2022》, which aims to sort out the development status and trends of the CRISPR/Cas9 industry at home and abroad, estimate the overall market scale of the CRISPR/Cas9 industry and the market share of major countries, CRISPR/Cas9 industry, and study and judge the downstream market demand of CRISPR/Cas9 through systematic research, Analyze the competition pattern of CRISPR/Cas9, so as to help solve the pain points of various stakeholders in CRISPR/Cas9 industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of CRISPR/Cas9 Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in CRISPR/Cas9 Market?
Caribou Biosciences
Integrated DNA Technologies(IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego
Major Type of CRISPR/Cas9 Covered in XYZResearch report:
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Application Segments Covered in XYZResearch Market
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

    Global CRISPR/Cas9 Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global CRISPR/Cas9 Market by Value
          • 2.2.1 Global CRISPR/Cas9 Revenue by Type
          • 2.2.2 Global CRISPR/Cas9 Market by Value (%)
        • 2.3 Global CRISPR/Cas9 Market by Production
          • 2.3.1 Global CRISPR/Cas9 Production by Type
          • 2.3.2 Global CRISPR/Cas9 Market by Production (%)

        3. The Major Driver of CRISPR/Cas9 Industry

        • 3.1 Historical & Forecast Global CRISPR/Cas9 Demand
        • 3.2 Largest Application for CRISPR/Cas9 (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional CRISPR/Cas9 Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of CRISPR/Cas9 Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US CRISPR/Cas9 Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe CRISPR/Cas9 Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China CRISPR/Cas9 Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan CRISPR/Cas9 Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India CRISPR/Cas9 Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea CRISPR/Cas9 Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia CRISPR/Cas9 Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global CRISPR/Cas9 Average Price Trend

        • 12.1 Market Price for Each Type of CRISPR/Cas9 in US (2018-2022)
        • 12.2 Market Price for Each Type of CRISPR/Cas9 in Europe (2018-2022)
        • 12.3 Market Price for Each Type of CRISPR/Cas9 in China (2018-2022)
        • 12.4 Market Price for Each Type of CRISPR/Cas9 in Japan (2018-2022)
        • 12.5 Market Price for Each Type of CRISPR/Cas9 in India (2018-2022)
        • 12.6 Market Price for Each Type of CRISPR/Cas9 in Korea (2018-2022)
        • 12.7 Market Price for Each Type of CRISPR/Cas9 in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 CRISPR/Cas9 Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of CRISPR/Cas9

        14. CRISPR/Cas9 Competitive Landscape

        • 14.1 Caribou Biosciences
          • 14.1.1 Caribou Biosciences Company Profiles
          • 14.1.2 Caribou Biosciences Product Introduction
          • 14.1.3 Caribou Biosciences CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 Integrated DNA Technologies(IDT)
          • 14.2.1 Integrated DNA Technologies(IDT) Company Profiles
          • 14.2.2 Integrated DNA Technologies(IDT) Product Introduction
          • 14.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 CRISPR Therapeutics
          • 14.3.1 CRISPR Therapeutics Company Profiles
          • 14.3.2 CRISPR Therapeutics Product Introduction
          • 14.3.3 CRISPR Therapeutics CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 Merck
          • 14.4.1 Merck Company Profiles
          • 14.4.2 Merck Product Introduction
          • 14.4.3 Merck CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 Mirus Bio
          • 14.5.1 Mirus Bio Company Profiles
          • 14.5.2 Mirus Bio Product Introduction
          • 14.5.3 Mirus Bio CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 Editas Medicine
          • 14.6.1 Editas Medicine Company Profiles
          • 14.6.2 Editas Medicine Product Introduction
          • 14.6.3 Editas Medicine CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives
        • 14.7 Takara Bio
          • 14.7.1 Takara Bio Company Profiles
          • 14.7.2 Takara Bio Product Introduction
          • 14.7.3 Takara Bio CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.7.4 Strategic initiatives
        • 14.8 Thermo Fisher Scientific
          • 14.8.1 Thermo Fisher Scientific Company Profiles
          • 14.8.2 Thermo Fisher Scientific Product Introduction
          • 14.8.3 Thermo Fisher Scientific CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.8.4 Strategic initiatives
        • 14.9 Horizon Discovery Group
          • 14.9.1 Horizon Discovery Group Company Profiles
          • 14.9.2 Horizon Discovery Group Product Introduction
          • 14.9.3 Horizon Discovery Group CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.9.4 Strategic initiatives
        • 14.10 Intellia Therapeutics
          • 14.10.1 Intellia Therapeutics Company Profiles
          • 14.10.2 Intellia Therapeutics Product Introduction
          • 14.10.3 Intellia Therapeutics CRISPR/Cas9 Sales, Revenue (2018-2022)
          • 14.10.4 Strategic initiatives
        • 14.11 Agilent Technologies
        • 14.12 Cellecta
        • 14.13 GenScript
        • 14.14 GeneCopoeia
        • 14.15 Synthego

        15. Conclusion

          16. Methodology and Data Source

          Summary:
          Get latest Market Research Reports on CRISPR/Cas9. Industry analysis & Market Report on CRISPR/Cas9 is a syndicated market report, published as (Post-pandemic Era)-Global CRISPR/Cas9 Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of CRISPR/Cas9 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

          Last updated on

          REPORT YOU MIGHT BE INTERESTED

          Purchase this Report

          $2,850.00
          $5,700.00
          2,359.80
          4,719.60
          2,790.15
          5,580.30
          384,807.00
          769,614.00
          226,489.50
          452,979.00
          Credit card Logo

          Related Reports


          Reason to Buy

          Request for Sample of this report